We are live on ! Find out more
NMC

NEA Management Company Portfolio holdings

AUM $1.76B
1-Year Est. Return 223.33%
This Fund
S&P 500
This Quarter Est. Return
-20.18%
1 Year Est. Return
+223.33%
3 Year Est. Return
+769.45%
5 Year Est. Return
+668.45%
10 Year Est. Return
+14,843.34%
AUM
$1.95B
AUM Growth
-$1.51B
Cap. Flow
-$541M
Cap. Flow %
-27.79%
Top 10 Hldgs %
66.18%
Holding
59
New
2
Increased
9
Reduced
3
Closed
2

Top Buys

Rank Stock Value
1
IVA
Inventiva
IVA
+$38.9M
2
SNTI icon
Senti Biosciences Holdings
SNTI
+$35.6M
3
TRVI icon
Trevi Therapeutics
TRVI
+$27.9M
4
PANW icon
Palo Alto Networks
PANW
+$17.4M
5
NKTX icon
Nkarta
NKTX
+$8.75M

Top Sells

Rank Stock Value
1
HOOD icon
Robinhood
HOOD
+$644M
2
IONQ icon
IonQ
IONQ
+$20.7M
3
GNCA
Genocea Biosciences, Inc.
GNCA
+$13M
4
ELVN icon
Enliven Therapeutics
ELVN
+$2.81M
5
LUMO
Lumos Pharma, Inc. Common Stock
LUMO
+$818K

Sector Composition

Rank Sector Weight
1 Healthcare 69.32%
2 Technology 12.48%
3 Consumer Staples 11.56%
4 Industrials 4.58%
5 Communication Services 1.21%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
NN icon
26
NextNav
NN
$2.02B
$18.6M 0.95%
8,189,156
– –
PANW icon
27
Palo Alto Networks
PANW
$296B
$15.4M 0.79%
+196,776
New +$17.4M
VTGN icon
28
VistaGen Therapeutics
VTGN
$12.2M
$14.3M 0.74%
543,420
– –
CVRX icon
29
CVRx
CVRX
$148M
$14.2M 0.73%
2,370,858
– –
CSBR icon
30
Champions Oncology
CSBR
$73.6M
$13.7M 0.7%
1,713,720
– –
STSA
31
DELISTED
Satsuma Pharmaceuticals, Inc. Common Stock
STSA
$13M 0.67%
3,142,958
– –
OKUR
32
OnKure Therapeutics
OKUR
$168M
$12.7M 0.65%
478,692
– –
AFMD
33
DELISTED
Affimed
AFMD
$12.3M 0.63%
442,649
– –
INZY
34
DELISTED
Inozyme Pharma
INZY
$10.5M 0.54%
2,444,379
– –
MILE
35
DELISTED
Metromile, Inc. Common Stock
MILE
$8.61M 0.44%
9,384,285
– –
BDTX icon
36
Black Diamond Therapeutics
BDTX
$103M
$8.49M 0.44%
3,449,845
– –
GLBE icon
37
Global E Online
GLBE
$6.98B
$7.92M 0.41%
436,282
– –
SNTI icon
38
Senti Biosciences Holdings
SNTI
$11.6M
$7.46M 0.38%
+442,973
New +$35.6M
OBSV
39
DELISTED
ObsEva SA Ordinary Shares
OBSV
$7.38M 0.38%
4,586,563
– –
BILL icon
40
BILL Holdings
BILL
$4.81B
$6.9M 0.35%
66,100
– –
ALLK
41
DELISTED
Allakos
ALLK
$6.78M 0.35%
2,164,704
– –
CBIO
42
Crescent Biopharma
CBIO
$586M
$5.43M 0.28%
90,890
– –
LITS
43
Lite Strategy Inc
LITS
$32.5M
$5.16M 0.27%
426,654
– –
XERS icon
44
Xeris Biopharma Holdings
XERS
$1.4B
$5M 0.26%
3,246,785
– –
SYBX
45
DELISTED
Synlogic
SYBX
$4.86M 0.25%
281,961
– –
MIMO
46
DELISTED
Airspan Networks Holdings Inc
MIMO
$4.59M 0.24%
1,534,633
+493
+0% +$1.38K
LXRX icon
47
Lexicon Pharmaceuticals
LXRX
$1.09B
$4.43M 0.23%
2,382,286
– –
PHAS
48
DELISTED
PhaseBio Pharmaceuticals, Inc. Common Stock
PHAS
$3.99M 0.2%
6,643,702
– –
MRKR icon
49
Marker Therapeutics
MRKR
$19M
$3.54M 0.18%
1,071,429
– –
EAR
50
DELISTED
Eargo, Inc. Common Stock
EAR
$3.4M 0.17%
226,042
+8
+0% +$378
1
2
3

Similar funds

NM
NWI Management New York $1.76B AUM 45.08% 1-Year Est. Return
SLF
Sun Life Financial Toronto, Ontario, Canada $1.76B AUM 19.57% 1-Year Est. Return
SW
Simplicity Wealth Summit, New Jersey $1.76B AUM 20.49% 1-Year Est. Return
CGH
Contrarius Group Holdings Hamilton, Bermuda $1.77B AUM 83.15% 1-Year Est. Return
PWP
Principle Wealth Partners Madison, Connecticut $1.75B AUM 21.63% 1-Year Est. Return
CIP
CAS Investment Partners Westport, Connecticut $1.75B AUM 41.95% 1-Year Est. Return
GD
Grandfield & Dodd New York $1.77B AUM 23.43% 1-Year Est. Return
DF
DNCA Finance Paris, France $1.75B AUM 38.18% 1-Year Est. Return

NEA Management Company's Q2 2022 Portfolio in Review

As of Q2 2022, NEA Management Company held 59 positions worth $1.95B, down 44% from $3.46B the previous quarter. Its ten largest holdings account for 66% of the portfolio.

NEA Management Company withdrew a net $541M in Q2 2022, closing 2 positions and reducing 3 holdings. Its most notable exit was Robinhood, an estimated $644M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 69% of assets, up from 53% a quarter earlier, followed by Technology and Consumer Staples.

Against the trend, NEA Management Company opened a new position in Senti Biosciences Holdings worth $7.46M.

  • NEA Management Company's largest Q2 2022 buy was Senti Biosciences Holdings: 442,973 shares worth $7.46M.
  • NEA Management Company added most to Inventiva in Q2 2022, an estimated $38.9M increase.
  • NEA Management Company's biggest Q2 2022 reduction was IonQ, cutting an estimated $20.7M.
  • NEA Management Company fully exited Robinhood in Q2 2022, selling an estimated $644M.
  • NEA Management Company's ten largest holdings make up 66% of its $1.95B portfolio in Q2 2022.
  • NEA Management Company opened 2 new positions and closed 2 in Q2 2022.
  • NEA Management Company's portfolio value fell 44% quarter-over-quarter to $1.95B.

Based on NEA Management Company's 13F filing for Q2 2022, filed 15 Aug 2022.